Possis Logo Printer Friendly Version

Download Financials

2005 Annual Report

Introduction
Thrombus Basics
Proprietary Technology
Market Presence
Business Model
Plans for Growth
Expanding Markets
Shareholder Letter
Glossary
Company Info
 
Board of Directors
Robert G. Dutcher
Chairman of the Board
Director since 1993
Chairman, President and
Chief Executive Officer
 
Mary K. Brainerd
Director since 2001
President and Chief Executive Officer,
HealthPartners, Inc.,
Minneapolis, MN
 
Seymour J. Mansfield

Director since 1987
Officer and Shareholder,
Mansfield, Tanick & Cohen, P.A.,
Minneapolis, MN
 
William C. Mattison, Jr.
Director since 1999
Retired. Formerly a Principal of
Gerard, Klauer Mattison & Co., Inc.,
New York, NY
 
Whitney A. McFarlin
Director since 1998
Retired. Former Chairman
of the Board, President
and Chief Executive Officer,
Angeion Corporation,
Minneapolis, MN
 
Donald C. Wegmiller
Director since 1987
Chairman, Clark Consulting
HealthCare Group,
Minneapolis, MN
 
Rodney A. Young
Director since 1999
President and
Chief Executive Officer,
Angeion Corporation,
Minneapolis, MN
 
Officers
Robert G. Dutcher
Chairman, President and
Chief Executive Officer
 
Jules L. Fisher
Vice President, Finance
and Chief Financial Officer
 
Irving R. Colacci
Vice President, Legal Affairs &
Human Resources, General Counsel,
Secretary and Chief Governance Officer
 
James D. Gustafson
Senior Vice President, Research,
Development, Engineering, Clinical
Evaluation, Chief Quality Officer
 
Shawn F. McCarrey
Executive Vice President,
Worldwide Sales and Marketing
 
Robert J. Scott
Vice President, Manufacturing
and Information Technology,
Chief Security Officer
 

Corporate Information

Auditors
Deloitte & Touche LLP, Minneapolis, MN
 
Legal Counsel
Dorsey & Whitney LLP, Minneapolis, MN
 
Transfer Agent
Wells Fargo Minnesota, N.A.
Shareowner Services
161 North Concord Exchange
P.O. Box 738
South Saint Paul, MN 55075-0738
Phone: (800) 468-9716
 
Annual Meeting
The annual meeting will be held
at the Radisson Plaza Hotel Conference Center, 35 South 7th Street, Minneapolis, MN
on December 7, 2005 at 4:00 p.m.
 
Form 10-K
A copy of the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission will be provided to shareholders without charge upon written request.

The Company has not paid cash dividends on its common stock since 1983. The Company currently does not anticipate paying cash dividends in the foreseeable future.

 

Investor Information

Shareholders, security analysts, and investors seeking additional information about the Company should call Investor Relations at (763) 780-4555. The following information may be obtained upon request from the Possis Medical Investor Relations Department, 9055 Evergreen Boulevard, N.W. Minneapolis, MN 55433-8003, USA.

  • News releases describing significant Company events and sales and earnings results for each quarter and the fiscal year.
  • Form 10-K Annual and Form 10-Q Quarterly Reports to the Securities and Exchange Commission detailing Possis’ business and financial condition.

News releases and other information can be accessed via the Internet at www.possis.com

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

The Company had 1,237 common shareholders of record at September 2, 2005. Our common stock is traded on the Nasdaq Stock Market under the symbol POSS. High and low closing sale prices for each quarter of fiscal years ended July 31, 2005 and 2004 are presented below:

  2005 2004
  High Low High Low
Quarter
First $30.76 $9.78 $19.37 $15.56
Second $13.98 $10.50 $24.94 $15.01
Third $12.20 $8.02 $29.79 $23.50
Fourth $11.70 $8.28 $34.15 $24.18